AN ACT CONCERNING COMPOUNDING PHARMACIES.

SB 434 would amend state law to allow compounding pharmacies to legally produce specific active pharmaceutical ingredients - such as those used in levonorgestrel, mifepristone, and misoprostol - to make certain drugs. This directly affects compounding pharmacies, enabling them to manufacture these drugs for patient access. The key provision removes legal barriers preventing pharmacies from compounding these ingredients for the listed medications. The bill focuses solely on clarifying pharmacy authority to ensure continued availability of these drugs, without altering drug approval or prescribing rules.